154 related articles for article (PubMed ID: 9231696)
21. Prophylaxis against lipopolysaccharide-induced liver injuries by lipoic acid in rats.
Suntres ZE
Pharmacol Res; 2003 Dec; 48(6):585-91. PubMed ID: 14527823
[TBL] [Abstract][Full Text] [Related]
22. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide-induced pleural neutrophil accumulation depends on marrow neutrophils and platelet-activating factor.
Bozza PT; Castro-Faria-Neto HC; Silva AR; Larangeira AP; Silva PM; Martins MA; Cordeiro RS
Eur J Pharmacol; 1994 Apr; 270(2-3):143-9. PubMed ID: 8039544
[TBL] [Abstract][Full Text] [Related]
24. The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats.
Howard KM; Olson MS
J Biol Chem; 2000 Jun; 275(26):19891-6. PubMed ID: 10748027
[TBL] [Abstract][Full Text] [Related]
25. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
Pearson JM; Schultze AE; Schwartz KA; Scott MA; Davis JM; Roth RA
J Pharmacol Exp Ther; 1996 Jul; 278(1):378-83. PubMed ID: 8764373
[TBL] [Abstract][Full Text] [Related]
26. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
27. Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock.
Schurr MJ; Fabian TC; Croce MA; Geraci SA; Proctor KG
Surgery; 1997 May; 121(5):493-500. PubMed ID: 9142146
[TBL] [Abstract][Full Text] [Related]
28. Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure.
Moulin F; Copple BL; Ganey PE; Roth RA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1423-31. PubMed ID: 11705747
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-alpha.
Ohata M; Suzuki H; Sakamoto K; Hashimoto K; Nakajima H; Yamauchi M; Hokkyo K; Yamada H; Toda G
Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):139S-144S. PubMed ID: 15318101
[TBL] [Abstract][Full Text] [Related]
30. Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.
Giral M; Balsa D; Ferrando R; Merlos M; Garcia-Rafanell J; Forn J
Br J Pharmacol; 1996 Jul; 118(5):1223-31. PubMed ID: 8818347
[TBL] [Abstract][Full Text] [Related]
31. Calpain inhibition attenuates iNOS production and midzonal hepatic necrosis in a repeat dose model of endotoxemia in rats.
Rose R; Banerjee A; Ramaiah SK
Toxicol Pathol; 2006; 34(6):785-94. PubMed ID: 17162536
[TBL] [Abstract][Full Text] [Related]
32. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
[TBL] [Abstract][Full Text] [Related]
33. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
34. Involvement of platelet-activating factor in the hypotensive response to zymosan in rats.
Damas J
J Lipid Mediat; 1991; 3(3):333-44. PubMed ID: 1773031
[TBL] [Abstract][Full Text] [Related]
35. Effect of inhibitors of leukotriene and/or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion.
Jung TT; Park SK; Rhee CK
Int J Pediatr Otorhinolaryngol; 2004 Jan; 68(1):57-63. PubMed ID: 14687688
[TBL] [Abstract][Full Text] [Related]
36. Modulation of endotoxin-induced inflammation in the bovine teat using antagonists/inhibitors to leukotrienes, platelet activating factor and interleukin 1 beta.
Waller KP
Vet Immunol Immunopathol; 1997 Jul; 57(3-4):239-51. PubMed ID: 9261962
[TBL] [Abstract][Full Text] [Related]
37. Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine.
Luyendyk JP; Shaw PJ; Green CD; Maddox JF; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1023-31. PubMed ID: 15933155
[TBL] [Abstract][Full Text] [Related]
38. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.
Gómez FP; Iglesia R; Roca J; Barberà JA; Chung KF; Rodriguez-Roisin R
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1559-64. PubMed ID: 9603138
[TBL] [Abstract][Full Text] [Related]
39. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
Jakubowski A; Olszanecki R; Chlopicki S
J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
[TBL] [Abstract][Full Text] [Related]
40. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
